Free Delivery Over $100
|
|
|||
|
||||
Overview"Around 1 percent of the US population suffers from this condition which ranges from life-altering to life-threatening. That includes over 3 million adults, and 470,000 children (under the age of 18). At its core, epilepsy is caused by irregular nerve functions in the brain that causes a variety of symptoms, the most notable being seizures.CBD's role in epilepsy treatment is what brought it mainstream, starting in the 1990s, leading to today. Its interaction with epilepsy symptoms is perhaps the most studied of all potential benefits CBD has to offer and the results of scientific and medical research are promising. They offer hope of relief to those who have traditionally had very little.Earlier this year, the American Epilepsy Society published the results of what has proved to be one of the most important and conclusive cannabis research studies ever done. The study tested the effects of CBD on 216 subjects with treatment-resistant epilepsy (TRE), and determined that the non-psychoactive cannabinoid caused a significant reduction in seizure frequency in over 60% of patients.Likewise, a simultaneous study out of New York University's Comprehensive Epilepsy Center produced similar results: out of 120 Dravet syndrome patients (Dravet is a rare, life-threatening, extremely debilitating epilepsy disorder), a reduction in seizure frequency was observed in over 39% of patients, with 5% of them going completely seizure free after the 14 week test period had ended.Most of the questions that people have regarding CBD for epilepsy revolve around what kind of specific product to use, and what specific dosage they need to administer.As far as products, CBD oil has by far proven to be the most effective form of treatment, though it can be very tough to find a reputable brand that manufactures a pure and reliable tincture. The FDA has actually issued official warnings to several brands in the past three years for advertising their products as ""pure CBD,"" when in fact they contained virtually none of the active cannabinoid." Full Product DetailsAuthor: Vincent EllwoodPublisher: Independently Published Imprint: Independently Published Dimensions: Width: 14.00cm , Height: 0.60cm , Length: 21.60cm Weight: 0.136kg ISBN: 9781657363205ISBN 10: 1657363201 Pages: 110 Publication Date: 08 January 2020 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Temporarily unavailable  The supplier advises that this item is temporarily unavailable. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out to you. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
